Skip to main content

pitolisant

Generic: pitolisant·Brand: WAKIX, Wakix

pitolisant: sourced relationships with 1 company · 5 clinical trials tracked.

pitolisant evidence translation

What we can confirm

What it means

Source-backed records connect pitolisant to HRMY; that link alone does not prove the drug works.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

How could pitolisant → HRMY affect its developer, and what evidence supports the link?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence4 indications · 0 study sponsors

Related indications

Idiopathic Hypersomnia; Prader-Willi Syndrome; Pregnancy RelatedIdiopathic HypersomniaNarcolepsyPrader-Willi Syndrome

Study sponsors

No additional listed-company sponsor is linked.

Dated Pipeline Records (1)
CompanyDated record stage
Harmony Biosciences Holdings, Inc. (HRMY)
licensee · Reported 2024-02-22 · Current development: unknownSource
Idiopathic Hypersomnia; Prader-Willi Syndrome; Pregnancy Rel…
Phase 3
Clinical Trial Registry Records (5)

An Open-Label Study to Evaluate Safety of Pitolisant in Participants With Prader-Willi Syndrome

NCT07219485Registry updated 2026-03-17·Phase 3
Enrolling by invitation

Primary endpoint: Percentage of participants reporting Treatment-Emergent Adverse Events (TEAEs)

Interventionalopen150 targetStarted 2025-08Completion 2030-081 site · United StatesHarmony Biosciences Management, Inc.

A Phase 3, Randomized, Double-Blind, Placebo-controlled, Efficacy and Safety Study of Pitolisant Followed by an Open-Label Extension in Patients With Prader-Willi Syndrome

NCT06366464Registry updated 2026-08-25·Phase 3
Recruiting

Primary endpoint: Change in severity of EDS as measured by Patient-Reported Outcomes Measurement Information System Bank v1.0 - Sleep-Related Impairment (PROMIS-SRI) T-score

InterventionalRandomizedquadruple134 targetStarted 2024-05Completion 2028-0450 sites · Australia, Belgium, Canada, Denmark…Harmony Biosciences Management, Inc.

An Open-Label Study to Evaluate the Long-Term Safety and Effectiveness of Pitolisant in Adult Patients With Idiopathic Hypersomnia Who Completed Study HBS-101-CL-010

NCT05458128Registry updated 2025-12-12·Phase 3
Completed

Primary endpoint: Safety and tolerability of pitolisant

Interventionalopen119 enrolledStarted 2022-08Completion 2025-1032 sites · United StatesHarmony Biosciences Management, Inc.

WAKIX® (Pitolisant) Pregnancy Registry: An Observational Study of the Safety of Pitolisant Exposure in Pregnant Women and Their Offspring

NCT05536011Registry updated 2026-06-12
Recruiting

Primary endpoint: Major congenital malformation

Observational1,329 targetStarted 2021-08Completion 2030-061 site · United StatesHarmony Biosciences Management, Inc.

A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate the Safety and Efficacy of Pitolisant in Patients With Prader-Willi Syndrome, Followed by an Open Label Extension

NCT04257929Registry updated 2026-05-12·Phase 2
Completed

Primary endpoint: Excessive Daytime Sleepiness

InterventionalRandomizedtriple65 enrolledStarted 2020-12Completion 2026-0113 sites · United StatesHarmony Biosciences Management, Inc.

Frequently asked questions

Which companies have sourced relationships with pitolisant?

pitolisant has dated SEC/FDA relationship records for Harmony Biosciences Holdings, Inc..

How many clinical trials involve pitolisant?

BioSniper tracks 5 clinical trials involving pitolisant.